Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: CVAS-an interesting california-based biotech company here

No earlier versions found for this Subject.

Return to CVAS-an interesting california-based biotech company here

CVAS--Corvas International, Inc. designs and develops therapeutic agents for cardiovascular, cancer, and other major diseases. The Company has an alliance with Pfizer Inc. to develop neutrophil inhibitory factor as possible stroke therapy. Corvas also has an alliance with Schering-Plough Corporation to develop an oral anticoagulant for chronic cardiovascular disease.

This stock has come up on a few scans recently, and I am wondering if perhaps it may garner some interest in the midst of an overall resurgence of the biotech sector.